← Leaderboards
Partha Basu
International Agency For Res On Cancer
$5,397,794
Attributed
$5,397,794
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $962.2K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,397,794 · 3
By mechanism
UH3$3,170,234 · 1
R37$1,730,892 · 1
UH2$496,668 · 1
Top collaborators
No co-investigators on record.
Most similar at International Agency For Res On Cancer
Same institution · by research overlap
- Maribel Almonte$2,831,005
- Rolando Herrero$973,980
- Rengaswamy Sankaranarayanan$428,496
Others in their field
Other Emerging Leaders on “Excision”
- Xinhua Li · Nano Terra, Inc.$26,433,300
- Shadi Dayeh · University Of California, San Diego$11,849,859
- Leah Johnson · Research Triangle Institute$10,876,154
- Deanna A Kulpa · Emory University$10,394,989
- Darren Baker · Mayo Clinic Rochester$7,821,986
- Jeffrey Benner · Drug Delivery Company, Llc, The$6,616,062
Research focus
ExcisionWomanField StudyDevicesMalignant Neoplasm Of Cervix UteriCervicalLow And Middle-Income CountriesEngineeringColposcopyVisualUser-FriendlyAcetic AcidsPerformanceCollaborationsZambiaPreventPortabilitySuccessMedicalEfficacy EvaluationLight WeightBaseHandHistopathological Examination
Grant awards (13)
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs$327,376
R37 · FY2025 · CA · contact PI
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs$301,187
R37 · FY2025 · CA · contact PI
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs$91,214
R37 · FY2025 · CA · contact PI
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs$491,802
R37 · FY2024 · CA · contact PI
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs$519,313
R37 · FY2023 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$442,901
UH3 · FY2023 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries -admin supplement$442,901
UH3 · FY2022 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$350,000
UH3 · FY2021 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$489,630
UH3 · FY2020 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$719,063
UH3 · FY2019 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$212,479
UH3 · FY2019 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$513,260
UH3 · FY2018 · CA · contact PI
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries$496,668
UH2 · FY2017 · CA · contact PI